Atypical Antipsychotics

Applications A metabolite of Ziprasidone (Z485000). References Huang, M., et al.: Clin. Pharmacol. Ther., 54, 257 (1993), Prakash, C., et al.: Drug Metab. Dispos., 25, 206 (1997), Brosen, K., et al.: Eur. J. Clin. Pharmacol., 44, 349 (1993),

Applications Combined serotonin (5HT2) and dopamine (D2) receptor antagonist; structurally related to labelled Mianserin. Antipsychotic. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Meltzer, H., et al.: J. Pharmacol. Exp. Ther., 251, 238 (1989), Schotte, A., et al.: Brain Res., 631, 191 (1993), Andree, B., et al.: Psychopharmacology, 131, 339 (1997), Richelson, E., et al.: Life Sci., 68, 29 (2000),

Applications Vigabatrin is a novel anti-epileptic drug. Antidepressant; antipsychotic; anxiolytic. References Vajda, F., et al.: Clin. Neurosci., 7, 88 (2000), Beghi, E., et al.: Lancet. Neurol., 3, 618 (2004), Sagirli, O., et al.: J. Pharmaceut. Biomed., 42, 618 (2006),

Applications A deuterated analog of Paliperidone, a combined serotonin (5-HT2) and dopamine (D2) receptor antagonist. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Tiberghien, F., et al.: Anticancer Drugs, 7, 568 (1996), Kansy, M., et al.: J. Med. Chem., 41, 1007 (1998), Kerns, E., et al.: J. Pharm. Sci., 90, 1838 (2001), Kerr, K., et al.: J. Biol. Chem., 276, 8657 (2001), Doran, A., et al.: Drug Metab. Dispos., 33, 165 (2005),

Applications Labelled Blonanserin (B595850). A 5-HT2 serotonin receptor and D2 dopamine receptor antagonist, used as an antipsychotic. References Oka, T., et al.: Life Sci., 76, 225 (2004), Singh, A., et al.: Int. Med. J., 12, 175 (2005), Ochi, T., et al.: Bioorg. Med. Chem., Lett., 15, 1055 (2005),

Stability Very Very Hygroscopic Applications Quetiapine is a dibenzothiazepine antipsychotic commonly used as monotherapy for patients with major depressive disorder and schizophrenia. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Cutler, A., et al.: J. Clin. Psych., 70, 526 (2009); Kapur, S., et al.: Arch. Gen. Psych., 57, 553 (2000); Peuskens, J. & Link, C.: Acta. Psych. Scand., 96, 265 (1997)

Impurity Chlorpromazine EP Impurity D Applications A metabolite of Chlorpromazine (C424750). Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Neuhoff, E., et al.: Archiv. der Pharmazie, 288, 400 (1955), Tomita, M., et al.: Chem. Pharm. Bull., 16, 688 (1968),

Applications 2-Dimethylsulfonamidophenothiazine is a derivative of Phenothiazine (P318040), a key component of antipsychotic and antihistaminic drugs. References Bansode, T., et al.: Eur. J. Med. Chem., 44, 5094 (2009); Baell, J., et al.: J. Med. Chem., 53, 2719 (2010); Howard, P., et al.: Environ. Sci. Technol., 44, 2277 (2010); Koren, J., et al.: J. Biol. Chem., 285, 2498 (2010); Amobi, N., et al.: Eur. J. Pharmacol., 627, 285 (2010),

Applications The cis(Z)-form of Clopenthixol. Thioxanthene neuroleptic. Antipsychotic. References Sabbe, B., et al.: J. Psychiatr. Res., 30, 295 (1996), Riley, E., et al.: Schizophr. Res., 43, 47 (2000), Green, M., et al.: Biol. Psychiatry., 51, 972 (2002), Morrens, M., et al.: J. Clin. Psychopharmacol., 27, 15 (2007),

Applications A metabolite of Loxapine. References Shen, Y., et al.: J. Biol. Chem., 268, 18200 (1993), Fiorella, D., et al.: Psychopharmacology, 121, 347 (1995), Glusa, E., and Pertz, H.: Brit. J. Pharmacol., 130, 692 (2000)

Applications (E)-Thiothixene is an antipsychotic agent used in the treatment of psychological disorders. References Andorn, A. et al.: Brain Res., 971, 66 (2003); Seeman, P. et al.: Mol. Pharmacol. 28, 391 (1985);

Applications Clothiapine-d8, is the labeled analogue of Clothiapine (C588550), a atypical antipsychotic of the dibenzothiazepine chemical class. It has shown efficacy in treatment-resistant schizophrenic patients. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Schmutz, J., et al.: Helvetica Chimica Acta 50, 245 (1967); Geller, V., et al.: Schizophrenia Research 80 (2-3), 343 (2005);

Applications Butyrophenone derivative having neuroleptic activity, used as an antipsychotic. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Shimoda, K., et al.: Pharmacol. Toxicol., 83, 164 (1998), Sekine, Y., et al.: Eur. J. Clin. Pharmacol., 55, 583 (1999), Oka, T., et al.: Life Sci., 76, 225 (2004), Fujikawa, M., et al.: Prog. Neuro-Psychopharmacol. Biol. Psych., 32, 755 (2008),

Applications Combined serotonin (5HT2) and dopamine (D2) receptor antagonist; structurally related to Mianserin. Antipsychotic. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Meltzer, H., et al.: J. Pharmacol. Exp. Ther., 251, 238 (1989), Schotte, A., et al.: Brain Res., 631, 191 (1993), Andree, B., et al.: Psychopharmacology, 131, 339 (1997), Richelson, E., et al.: Life Sci., 68, 29 (2000),

Applications A metabolite of Fluphenazine (F598400). References Cooper, J., et al.: Ther. Drug Monit., 11, 354 (1989), Prakash, C., et al.: Drug Metab. Dispos., 25, 863 (1997), Weinmann, W., et al.: J. Anal. Toxicol., 26, 303 (2002),